Delivery Order SPE2DE24D0013-SPE2D626F52B2
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $3,638 for COVID-19/Influenza/RSV diagnostic supplies. The delivery order, issued on December 10, 2025, with an ultimate completion date of December 24, 2025, represents a routine procurement action under the DLA Medical Supply Chain's established contracting framework for infectious disease testing solutions. No...
- On November 26, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,120 to Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, calls for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus. The order is scheduled for completion by December 4, 2025, and carries no set-aside designation....
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on December 18, 2025, for COVID-19/Influenza/Respiratory Syncytial Virus (RSV) diagnostic test kits containing 10 viral tests. The contract is scheduled for completion by December 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents routine procurement of molecular diagnostic testing supplies, consistent with the Defense...
- On December 22, 2025, the Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $6,800 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement activity under a larger indefinite delivery contract and is scheduled for completion by December 30, 2025. The award carries no set-aside designation, reflecting Cepheid's competitive...
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 3, 2025, for the XPert Xpress COVID-19, Flu, and RSV molecular diagnostic kit with an ultimate completion date of December 10, 2025. This delivery order represents a continuation of Cepheid's established role as a primary federal supplier of rapid molecular diagnostic testing solutions. The work will be performed at Cepheid's facility in Sunnyvale, California. No...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on December 22, 2025, for diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The delivery order, which extends through December 30, 2025, represents a continuation of the federal government's reliance on Cepheid's molecular diagnostic capabilities. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F52B2Delivery Order
On December 22, 2025, the Defense Logistics Agency Medical Supply Chain awarded a $34,000 firm fixed-price delivery order to Cepheid Inc. for the XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits with ultimate completion by December 31, 2025. This delivery order represents a discrete procurement action under Cepheid's broader contracting relationship with the federal healthcare system. Cepheid, headquartered in Sunnyvale, California, is a specialized manufacturer of advanced molecular diagnostic systems and reagents, with established expertise in rapid infectious disease detection through its GeneXpert diagnostic platform. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in federal molecular diagnostics procurement. This procurement supports the Defense Logistics Agency's Medical Supply Chain operations and aligns with Cepheid's extensive federal healthcare portfolio, which includes primary supplier relationships with the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. Cepheid currently holds two significant Indefinite Delivery Contracts with the VA—including a $32.8 million agreement with VISN 6 through September 2030—that establish the framework for ongoing procurement of molecular diagnostic solutions across the federal healthcare system. The current $34,000 delivery order reflects the continued demand for Cepheid's respiratory pathogen testing capabilities within federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 12/21/25 |